Limners and Bards Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Los beneficios de Limners and Bards han disminuido a una tasa media anual de -1.5%, mientras que en la industria Media los beneficios crecieron en un 10% anualmente. Los ingresos han ido creciendo a una tasa media de 14.8% al año. La rentabilidad financiera de Limners and Bards es de 12.3%, y sus márgenes netos son de 7%.

Información clave

-8.5%

Tasa de crecimiento de los beneficios

-9.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Media	9.4%
Tasa de crecimiento de los ingresos	8.9%
Rentabilidad financiera	12.3%
Margen neto	8.7%
Última actualización de beneficios	31 Jul 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Limners and Bards. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

JMSE:LAB Ingresos, gastos y beneficios (JMD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Jul 24	964	84	294
30 Apr 24	1,031	86	310
31 Jan 24	1,096	77	325
31 Oct 23	1,125	57	342
31 Jul 23	1,147	57	352
30 Apr 23	1,102	41	345
31 Jan 23	1,149	83	334
31 Oct 22	1,345	144	322
31 Jul 22	1,396	158	310
30 Apr 22	1,390	165	287
31 Jan 22	1,314	156	260
31 Oct 21	1,227	156	240
31 Jul 21	1,168	161	214
30 Apr 21	1,059	154	197
31 Jan 21	1,005	145	187
31 Oct 20	912	127	175
31 Jul 20	832	133	156
30 Apr 20	769	124	146
31 Jan 20	705	111	134
31 Oct 19	632	95	118
31 Jul 19	578	73	106
30 Apr 19	557	66	98
31 Jan 19	542	68	90
31 Oct 18	483	62	82
31 Oct 17	291	-3	95

Ingresos de calidad: LAB tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: Los actuales márgenes de beneficio (8.4%) de LAB son superiores a los del año pasado (3.7%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de LAB han disminuido en un 1.5% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de LAB en el último año (110.1%) supera su media de 5 años (-4.9% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de LAB en el último año (110.1%) superó al de la industria Media 81.4%.

Limners and Bards Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings released: EPS: JA$0.04 (vs JA$0.04 in 3Q 2023)

Second quarter 2024 earnings released

First quarter 2024 earnings released: EPS: JA$0.03 (vs JA$0.01 in 1Q 2023)

Third quarter 2023 earnings released: EPS: JA$0.04 (vs JA$0.02 in 3Q 2022)

Second quarter 2023 earnings released: EPS: JA$0.01 (vs JA$0.06 in 2Q 2022)

First quarter 2023 earnings released: EPS: JA$0.01 (vs JA$0.07 in 1Q 2022)

Recent updates

Investor sentiment deteriorates as stock falls 23%

Third quarter 2024 earnings released: EPS: JA$0.04 (vs JA$0.04 in 3Q 2023)

Now 22% overvalued

The Limners and Bards Limited Approves Interim Dividend, Payable on October 10, 2024

Investor sentiment improves as stock rises 26%

Now 34% overvalued after recent price rise

Investor sentiment improves as stock rises 16%

Now 32% overvalued

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 22%

Second quarter 2024 earnings released

Investor sentiment improves as stock rises 23%

Investor sentiment improves as stock rises 22%

Now 24% undervalued after recent price drop

The Limners and Bards Limited, Annual General Meeting, Jul 18, 2024

Investor sentiment improves as stock rises 17%

Now 46% overvalued after recent price rise

First quarter 2024 earnings released: EPS: JA$0.03 (vs JA$0.01 in 1Q 2023)

Investor sentiment improves as stock rises 25%

Investor sentiment improves as stock rises 24%

Investor sentiment deteriorates as stock falls 16%

New major risk - Market cap size

Investor sentiment improves as stock rises 23%

Third quarter 2023 earnings released: EPS: JA$0.04 (vs JA$0.02 in 3Q 2022)

Investor sentiment improves as stock rises 16%

Second quarter 2023 earnings released: EPS: JA$0.01 (vs JA$0.06 in 2Q 2022)

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: JA$0.01 (vs JA$0.07 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings released: EPS: JA$0.15 (vs JA$0.16 in FY 2021)

Investor sentiment improved over the past week

Insufficient new directors

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: JA$0.02 (vs JA$0.03 in 3Q 2021)

Investor sentiment improved over the past week

Upcoming dividend of JA$0.039 per share

Insufficient new directors

Investor sentiment improved over the past week

Upcoming dividend of JA$0.013 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS JA$0.03 (vs JA$0.02 in 3Q 2020)

Investor sentiment improved over the past week

Upcoming dividend of JA$0.036 per share

Second quarter 2021 earnings released: EPS JA$0.05 (vs JA$0.04 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released

Full year 2020 earnings released: EPS JA$0.13

Investor sentiment improved over the past week

New 90-day high: JA$3.00

Market bids up stock over the past week

Third quarter earnings released

New 90-day high - JA$2.96

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado